Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain

Open access

Abstract

Recombinant Adeno-associated virus vectors (rAAV) are widely used for gene delivery and multiple naturally occurring serotypes have been harnessed to target cells in different tissues and organs including the brain. Here, we provide a detailed and quantitative analysis of the transduction profiles of rAAV vectors based on six of the most commonly used serotypes (AAV1, AAV2, AAV5, AAV6, AAV8, AAV9) that allows systematic comparison and selection of the optimal vector for a specific application. In our studies we observed marked differences among serotypes in the efficiency to transduce three different brain regions namely the striatum, hippocampus and neocortex of the mouse. Despite the fact that the analyzed serotypes have the general ability to transduce all major cell types in the brain (neurons, microglia, astrocytes and oligodendrocytes), the expression level of a reporter gene driven from a ubiquitous promoter varies significantly for specific cell type / serotype combinations. For example, rAAV8 is particularly efficient to drive transgene expression in astrocytes while rAAV9 appears well suited for the transduction of cortical neurons. Interestingly, we demonstrate selective retrograde transport of rAAV5 along axons projecting from the ventral part of the entorhinal cortex to the dentate gyrus. Furthermore, we show that self-complementing rAAV can be used to significantly decrease the time required for the onset of transgene expression in the mouse brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0076310

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 General expression efficacy in striatum, hippocampus and auditory cortex. A) Left: six confocal fluorescence images of the striatum taken from mice injected with various AAV serotypes as indicated in the panels. Blue: DAPI, green: GFP. Right, top: schematic of a coronal brain section with red box indicating the position of the images shown on the left with reference to Bregma. Right, bottom: Mean fluorescence index (see methods) for the striatal sections measured following transduction with the different serotypes. Number of analyzed mice shown at the bottom of the bars. B) Same as A), however, showing images and data from mice that received injections in the hippocampus. C) Same as A), however, showing images and data from mice that received injections in the auditory cortex. Acquisition and display settings for images from a given brain area are the same for different serotypes. All scale bars: 500 µm. All bars represent mean±SEM. Asterisks indicate significant differences at the p<0.05 level.
Figure 1 General expression efficacy in striatum, hippocampus and auditory cortex. A) Left: six confocal fluorescence images of the striatum taken from mice injected with various AAV serotypes as indicated in the panels. Blue: DAPI, green: GFP. Right, top: schematic of a coronal brain section with red box indicating the position of the images shown on the left with reference to Bregma. Right, bottom: Mean fluorescence index (see methods) for the striatal sections measured following transduction with the different serotypes. Number of analyzed mice shown at the bottom of the bars. B) Same as A), however, showing images and data from mice that received injections in the hippocampus. C) Same as A), however, showing images and data from mice that received injections in the auditory cortex. Acquisition and display settings for images from a given brain area are the same for different serotypes. All scale bars: 500 µm. All bars represent mean±SEM. Asterisks indicate significant differences at the p<0.05 level.CC BY · PubMed Central
Figure 2 Expression efficacy in immunohistochemically identified cell-types. A) Confocal images of brain sections of the hippocampus prepared from mice that received injections of rAAV5 (left) and rAAV8 (right). Red channel: immunohistochemical label for GFAP, an astrocyte marker; blue channel: DAPI, labeling nuclei, green channel: GFP expression driven by viral vector. Examples of individual immunohistochemically identified cell bodies are marked with white arrowheads. B) Cumulative distributions of fluorescence measurements from individual cells expressed as ‘fold background’ (see methods). Individual lines correspond to a given analyzed section. Note, that cumulative distributions for astrocytes obtained from rAAV8 transduced mice are systematically shifted towards higher fluorescence levels as compared to rAAV5 transduced mice. C) Confocal images of brain sections of the auditory cortex prepared from mice that received injections of rAAV1 (left) and rAAV9 (right). Red channel: immunohistochemical label for NeuN, a neuron marker; blue channel: DAPI, labeling nuclei, green channel: GFP expression driven by viral vector. Examples of individual immunohistochemically identified cell bodies are marked with white arrowheads. D) Cumulative distributions of fluorescence measurements from individual cortical neurons expressed as fold background. All scale bars: 25 µm.
Figure 2 Expression efficacy in immunohistochemically identified cell-types. A) Confocal images of brain sections of the hippocampus prepared from mice that received injections of rAAV5 (left) and rAAV8 (right). Red channel: immunohistochemical label for GFAP, an astrocyte marker; blue channel: DAPI, labeling nuclei, green channel: GFP expression driven by viral vector. Examples of individual immunohistochemically identified cell bodies are marked with white arrowheads. B) Cumulative distributions of fluorescence measurements from individual cells expressed as ‘fold background’ (see methods). Individual lines correspond to a given analyzed section. Note, that cumulative distributions for astrocytes obtained from rAAV8 transduced mice are systematically shifted towards higher fluorescence levels as compared to rAAV5 transduced mice. C) Confocal images of brain sections of the auditory cortex prepared from mice that received injections of rAAV1 (left) and rAAV9 (right). Red channel: immunohistochemical label for NeuN, a neuron marker; blue channel: DAPI, labeling nuclei, green channel: GFP expression driven by viral vector. Examples of individual immunohistochemically identified cell bodies are marked with white arrowheads. D) Cumulative distributions of fluorescence measurements from individual cortical neurons expressed as fold background. All scale bars: 25 µm.CC BY · PubMed Central
Figure 3 Summary of cell-type specific expression analysis. A) Data obtained from striatum: average of the median florescence levels for oligodendrocytes, microglia, astrocytes, neurons and inhibitory neurons for all of the analyzed six serotypes. Number of analyzed sections is shown at the bottom of the bars. Statistical analysis of fluorescence measurements shown below bar graphs. Asterisks indicate significant differences at the p<0.05 level. B) same as A), however, showing data obtained from hippocampal injections. C) same as A), however, showing data obtained from auditory cortex injections. All bars represent mean±SEM.
Figure 3 Summary of cell-type specific expression analysis. A) Data obtained from striatum: average of the median florescence levels for oligodendrocytes, microglia, astrocytes, neurons and inhibitory neurons for all of the analyzed six serotypes. Number of analyzed sections is shown at the bottom of the bars. Statistical analysis of fluorescence measurements shown below bar graphs. Asterisks indicate significant differences at the p<0.05 level. B) same as A), however, showing data obtained from hippocampal injections. C) same as A), however, showing data obtained from auditory cortex injections. All bars represent mean±SEM.CC BY · PubMed Central
Figure 4 Density of microglia in transduced areas. A) Confocal images taken from the ipsilateral (left) and contralateral (right) striatum of mice that received an injection of LPS. Red channel: immunohistochemical label for Iba1, a marker for microglia. Individual cell bodies of microglia are marked with white arrowheads. Note the high number of microglia in the ipsilateral striatum. B) same as A), however, showing images obtained from mice that received an injection of rAAV9 in the striatum. Note, that microglia counts are low in both hemispheres. Scale bars: 10 µm. C) Quantification of ipsilateral and contralateral microglia densities in the striatum of mice with rAAV and LPS injections. Number of analyzed sections is shown at bottom of bars. D) Ipsilateral and contralateral density of microglia in the hippocampus of mice following rAAV injections. E) Ipsilateral and contralateral density of microglia in the auditory cortex of mice following rAAV injections. All bars represent mean±SEM.
Figure 4 Density of microglia in transduced areas. A) Confocal images taken from the ipsilateral (left) and contralateral (right) striatum of mice that received an injection of LPS. Red channel: immunohistochemical label for Iba1, a marker for microglia. Individual cell bodies of microglia are marked with white arrowheads. Note the high number of microglia in the ipsilateral striatum. B) same as A), however, showing images obtained from mice that received an injection of rAAV9 in the striatum. Note, that microglia counts are low in both hemispheres. Scale bars: 10 µm. C) Quantification of ipsilateral and contralateral microglia densities in the striatum of mice with rAAV and LPS injections. Number of analyzed sections is shown at bottom of bars. D) Ipsilateral and contralateral density of microglia in the hippocampus of mice following rAAV injections. E) Ipsilateral and contralateral density of microglia in the auditory cortex of mice following rAAV injections. All bars represent mean±SEM.CC BY · PubMed Central
Figure 5 rAAV5 injections in the dentate gyrus lead to retrograde labeling of cells in the ventral entorhinal cortex. A) Confocal images from horizontal brain sections at -3 mm along the dorso-ventral axis in reference to Bregma taken from a mouse that received a co-injection of rAAV5 driving expression of GFP (green) and fluorescently labeled retrograde tracer CTB (red) in the dentate gyrus. B) same as A), for Bregma -4.5 mm. C) same as A), for Bregma -6.0 mm. Double labeled cells in the ventral entorhinal cortex appear yellow. White squares on the left indicate parts of images shown in higher magnification on the right. Scale bars: for whole sections: 1 mm; for insets: 250 µm. D) Cell counts of CTB-only labeled cells (red), GFP-only labeled cells (green) and double positive cells (yellow) in horizontal sections of the ipsilateral entorhinal cortex along the dorso-ventral axis of three individual mice.
Figure 5 rAAV5 injections in the dentate gyrus lead to retrograde labeling of cells in the ventral entorhinal cortex. A) Confocal images from horizontal brain sections at -3 mm along the dorso-ventral axis in reference to Bregma taken from a mouse that received a co-injection of rAAV5 driving expression of GFP (green) and fluorescently labeled retrograde tracer CTB (red) in the dentate gyrus. B) same as A), for Bregma -4.5 mm. C) same as A), for Bregma -6.0 mm. Double labeled cells in the ventral entorhinal cortex appear yellow. White squares on the left indicate parts of images shown in higher magnification on the right. Scale bars: for whole sections: 1 mm; for insets: 250 µm. D) Cell counts of CTB-only labeled cells (red), GFP-only labeled cells (green) and double positive cells (yellow) in horizontal sections of the ipsilateral entorhinal cortex along the dorso-ventral axis of three individual mice.CC BY · PubMed Central
Figure 6 Retrogradely labeled cells in the entorhinal cortex are excitatory neurons. A) Confocal fluorescence images of the same horizontal section of the ventral entorhinal cortex of a mouse that received a co-injection of rAAV5 driving GFP expression (green) and fluorescently labeled CTB (red) that was stained with DAPI (blue) and immunohistochemically labeled against the neuronal marker NeuN (magenta). Examples of individual GFP and CTB-labeled neurons are marked with white arrowheads. The white square denotes the area shown in higher magnification. Scale bars: low magnification: 100 µm, high magnification: 50 µm. B) Quantification of CTB positive cells and GFP positive cells (bars: mean±SEM; CTB: n= 918 cells, 4 sections, one mouse; GFP: n=264 cells, 4 sections, one mouse) with the neuronal marker NeuN showing in both cases almost complete co-labeling. C) Confocal fluorescence images of the same horizontal section of the ventral entorhinal cortex of a transgenic mouse in which GAD2-expressing interneurons are labeled by tdTomato (red) that received an injection of rAAV5 driving GFP expression (green) that was stained with DAPI (blue). Individual interneurons are marked with white arrowheads. The white square denotes the area shown in higher magnification. Scale bars: low magnification: 100 µm and high magnification: 50 µm) D) Quantification of GAD2-expressing interneurons and rAAV5 transduced neurons showing disjunct populations (bars: mean±SEM; n=1033 cells, 4 sections, one mouse).
Figure 6 Retrogradely labeled cells in the entorhinal cortex are excitatory neurons. A) Confocal fluorescence images of the same horizontal section of the ventral entorhinal cortex of a mouse that received a co-injection of rAAV5 driving GFP expression (green) and fluorescently labeled CTB (red) that was stained with DAPI (blue) and immunohistochemically labeled against the neuronal marker NeuN (magenta). Examples of individual GFP and CTB-labeled neurons are marked with white arrowheads. The white square denotes the area shown in higher magnification. Scale bars: low magnification: 100 µm, high magnification: 50 µm. B) Quantification of CTB positive cells and GFP positive cells (bars: mean±SEM; CTB: n= 918 cells, 4 sections, one mouse; GFP: n=264 cells, 4 sections, one mouse) with the neuronal marker NeuN showing in both cases almost complete co-labeling. C) Confocal fluorescence images of the same horizontal section of the ventral entorhinal cortex of a transgenic mouse in which GAD2-expressing interneurons are labeled by tdTomato (red) that received an injection of rAAV5 driving GFP expression (green) that was stained with DAPI (blue). Individual interneurons are marked with white arrowheads. The white square denotes the area shown in higher magnification. Scale bars: low magnification: 100 µm and high magnification: 50 µm) D) Quantification of GAD2-expressing interneurons and rAAV5 transduced neurons showing disjunct populations (bars: mean±SEM; n=1033 cells, 4 sections, one mouse).CC BY · PubMed Central
Figure 7 Time course of expression in striatal neurons transduced in vivo with ssAAV or scAAV. A) Schematics of the ssAAV and scAAV constructs driving expression of an H2B-GFP fusion protein under the control of the neuronal human Synapsin 1 promoter that have been packaged in AAV8 capsids. B) High-magnification confocal fluorescence image of a coronal striatal section containing scAAV-transduced neurons that was stained with nuclear stain DAPI (blue) showing localization of the H2B-GFP fusion protein (green) in the nucleus. Scale bar: 25 µm. C) Schematic of a coronal brain section in reference to Bregma with a red box indicating the areas shown in D. D) Confocal fluorescence images of coronal striatal sections stained with DAPI (blue) prepared at increasing time points following injection of ssAAV (top row) or scAAV (bottom row). Green GFP expression in neurons becomes visible in ssAAV at eight days, whereas scAAV leads to earlier expression already at three days after injection. Scale bars: 250 µm. E) Cumulative distributions of mean fluorescence in the green channel of individual nuclei identified based on DAPI signal. Each line corresponds to the distribution of a brain section from one injected mouse (region of interest with a fixed size corresponding to approx. 15028±341 (mean±SEM) cells). Fluorescence measurements below 2.6 AU correspond mostly to non-expressing cells (e.g. 12 hour time point), whereas an appreciable fraction of cells in the striatum show intensities well above 2.6 AU as can be seen following longer incubation periods (e.g. 21 day time point). Dashed vertical line corresponds to 2.6 AU threshold. Two sections from two injected mice per virus type were analyzed on each time point. F) Fraction of cells within region of interest that show fluorescence levels higher than 2.6 AU corresponding to classification of ‘GFP-expressing’ (Bars represent mean of two mice). G) Mean fluorescence of all cells with intensities higher than 2.6 AU. Note that not only the number of ‘GFP-expressing’ cells increases with time, but also their intensity levels.
Figure 7 Time course of expression in striatal neurons transduced in vivo with ssAAV or scAAV. A) Schematics of the ssAAV and scAAV constructs driving expression of an H2B-GFP fusion protein under the control of the neuronal human Synapsin 1 promoter that have been packaged in AAV8 capsids. B) High-magnification confocal fluorescence image of a coronal striatal section containing scAAV-transduced neurons that was stained with nuclear stain DAPI (blue) showing localization of the H2B-GFP fusion protein (green) in the nucleus. Scale bar: 25 µm. C) Schematic of a coronal brain section in reference to Bregma with a red box indicating the areas shown in D. D) Confocal fluorescence images of coronal striatal sections stained with DAPI (blue) prepared at increasing time points following injection of ssAAV (top row) or scAAV (bottom row). Green GFP expression in neurons becomes visible in ssAAV at eight days, whereas scAAV leads to earlier expression already at three days after injection. Scale bars: 250 µm. E) Cumulative distributions of mean fluorescence in the green channel of individual nuclei identified based on DAPI signal. Each line corresponds to the distribution of a brain section from one injected mouse (region of interest with a fixed size corresponding to approx. 15028±341 (mean±SEM) cells). Fluorescence measurements below 2.6 AU correspond mostly to non-expressing cells (e.g. 12 hour time point), whereas an appreciable fraction of cells in the striatum show intensities well above 2.6 AU as can be seen following longer incubation periods (e.g. 21 day time point). Dashed vertical line corresponds to 2.6 AU threshold. Two sections from two injected mice per virus type were analyzed on each time point. F) Fraction of cells within region of interest that show fluorescence levels higher than 2.6 AU corresponding to classification of ‘GFP-expressing’ (Bars represent mean of two mice). G) Mean fluorescence of all cells with intensities higher than 2.6 AU. Note that not only the number of ‘GFP-expressing’ cells increases with time, but also their intensity levels.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Cited by

See all 557

Metadata

Authors
Aschauer, D. F., Kreuz, S., & Rumpel, S.
Affiliations
  • Research Institute of Molecular Pathology (AT)
  • Boehringer Ingelheim (Germany) (DE)
Corresponding author
Rumpel, Simon
Venue
PLoS ONE
Published
2013-09-27
Volume
8
Issue
9
Pages
e76310
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2015741711
Cited by
522
References
68
Citations by year
2026: 26 · 2025: 31 · 2024: 47 · 2023: 44 · 2022: 40 · 2021: 49 · 2020: 44 · 2019: 57 · 2018: 45 · 2017: 42 · 2016: 42 · 2015: 34 · 2014: 20 · 2013: 1
FWCI
21.43
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
adeno-associated virus vectors, AAV serotypes, AAV1, AAV2, AAV5, AAV6, AAV8, AAV9, transduction efficiency, axonal transport, retrograde transport, self-complementary AAV, gene delivery to the brain, striatum, hippocampus, neocortex, astrocytes, cortical neurons, microglia, oligodendrocytes, entorhinal cortex, dentate gyrus, reporter gene expression
MeSH terms
Dependovirus, Analysis of Variance, Animals, Axonal Transport, Brain, Cloning, Molecular, Gene Expression Regulation, Genetic Vectors, Microscopy, Fluorescence, Organ Specificity, Transduction, Genetic, Gene Transfer Techniques, Transgenes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain. https://app.cochat.ai/papers/10.1371/journal.pone.0076310
The paper
Aschauer, D. F., Kreuz, S., & Rumpel, S. (2013). Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain. PLoS ONE. https://doi.org/10.1371/journal.pone.0076310

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.